Nasiri M J, Heidary M, Azimi T, Goudarzi H, Tabarsi P, Sarokhalil D D, Feizabadi M M
Department of Microbiology, School of Medicine, Tehran, Iran.
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
New Microbes New Infect. 2018 Sep 22;26:118-123. doi: 10.1016/j.nmni.2018.09.008. eCollection 2018 Nov.
is one of the most common nontuberculous mycobacteria (NTM) microorganisms causing lung disease in many countries in the world. A reliable estimate of the extent of pulmonary disease has not been well investigated in Iran. We systematically searched multiple databases to identify relative studies. Studies were excluded if they did not use the American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) diagnostic criteria for NTM diseases. Data were extracted independently and in duplicate. We assessed pooled estimate by using a random model effect, and sources of heterogeneity were assessed by using Cochran's and the statistic. The potential for publication bias was explored by using Begg's and Egger's tests. All analyses were conducted with Stata 14.0 (StataCorp, College Station, TX, USA). Of 172 articles identified, seven met the inclusion criteria. Of 355 patients who were culture positive for NTM, 82 had M pulmonary disease according to the ATS/IDSA diagnostic criteria. The pooled frequency of pulmonary disease among patients with NTM was 25.0% (95% confidence interval, 16.8-33.2). No evidence of publication bias was observed among the included studies (p >0.05 for Begg's and Egger's tests). Clinical isolates of are increasingly being recognized as a cause of pulmonary disease in Iran and need further attention by health authorities.
是世界上许多国家导致肺部疾病的最常见非结核分枝杆菌(NTM)微生物之一。在伊朗,尚未对肺部疾病范围的可靠估计进行充分研究。我们系统地检索了多个数据库以识别相关研究。如果研究未使用美国胸科学会(ATS)和美国传染病学会(IDSA)的NTM疾病诊断标准,则将其排除。数据由两人独立提取。我们使用随机模型效应评估合并估计值,并使用Cochran's检验和统计量评估异质性来源。通过使用Begg检验和Egger检验探讨发表偏倚的可能性。所有分析均使用Stata 14.0(美国德克萨斯州大学站的StataCorp公司)进行。在识别出的172篇文章中,有7篇符合纳入标准。在355例NTM培养阳性的患者中,根据ATS/IDSA诊断标准,有82例患有肺病。NTM患者中肺病的合并发生率为25.0%(95%置信区间,16.8 - 33.2)。在所纳入的研究中未观察到发表偏倚的证据(Begg检验和Egger检验的p>0.05)。在伊朗,的临床分离株越来越被认为是肺部疾病的一个病因,需要卫生当局进一步关注。